Oct 31 (Reuters) - Bubs Australia Ltd (BUB) :
- Q1 GROUP GROSS REVENUE A$23.6M, UP 28% PCP
- U.S. FDA REGULATORY PATHWAY FOR PERMANENT ACCESS BY OCTOBER 2025 CONFIRMED
- BUBS INFANT FORMULA Q1 GROSS REVENUE MORE THAN DOUBLED, UP 109% PCP
- CHINA DAIGOU INFANT FORMULA Q1 GROSS REVENUE INCREASED 20% PCP
News: BUB Bubs Australia Says Q1 Group Gross Revenue A$23.6M
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $145.1M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.3¢ | $52.92K | 321.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 1813295 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 424175 | 16 |
View Market Depth
| Last trade - 15.01pm 11/08/2025 (20 minute delay) ? |
| BUB (ASX) Chart |